Publications by authors named "Giulia Di Colo"

Claim this Profile
E
Early bone marrow alterations in patients with adenosine deaminase 2 deficiency across disease phenotypes and severities.
Dimitri Bulté, Federica Barzaghi, Cristina Mesa-Nuñez, Chiara Rigamonti, Luca Basso-Ricci, Giulia Di Colo

J Allergy Clin Immunol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency.
Federica Barzaghi, Maria Pia Cicalese, Matteo Zoccolillo, Immacolata Brigida, Matteo Barcella, Giulia Di Colo

Front Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease.
Gaia Mancuso, Tatiana Jofra, Marco Lanzillotta, Alessandro Aiuti, Maria Pia Cicalese, Giulia di Colo

Rheumatology (Oxford)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes for adults with chronic granulomatous disease in the United Kingdom.
Luiza C Campos, Giulia Di Colo, Vruti Dattani, Helen Braggins, Dinakantha Kumararatne

J Allergy Clin Immunol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study.
Emanuel Della-Torre, Marco Lanzillotta, Corrado Campochiaro, Giulia Di-Colo, Gaia Mancuso

Eur J Intern Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis